Escient Pharmaceuticals

About:

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

Website: http://www.escientpharma.com/

Twitter/X: escientp

Top Investors: New Enterprise Associates, Perceptive Advisors, The Column Group, Abingworth, 5AM Ventures

Description:

Escient Pharmaceuticals is a provider of bio-technical research and development services intended to focus on the advancement of first-in-class G Protein-Coupled Receptor targeted drugs. Its services focus on offering therapies for neuro-immuno-inflammatory and autoreactive diseases.

Total Funding Amount:

$238M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2018-05-01

Contact Email:

info(AT)escientpharma.com

Founders:

Alain D. Baron, Marcus F. Boehm

Number of Employees:

11-50

Last Funding Date:

2022-11-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai